Treatment

PF-06801591 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE3
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
This study looked at a new medicine called sasanlimab for early-stage bladder cancer that hasn't spread. It compared sasanlimab with or without BCG, a common bladder cancer treatment. The goal was to see how safe and effective sasanlimab is in preventing the cancer from coming back.
For: Non-muscle Invasive Bladder Cancer
United States · Australia · Belgium